Movement Disorders (revue) - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Membrane Transport Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Membrane Proteins < Membrane Transport Proteins < Memory  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 47.
[20-40] [0 - 20][0 - 47][40-46][40-60]
Ident.Authors (with country if any)Title
003650 (2003) Wolfgang H. Oertel [Allemagne] ; Anja Gerstner ; Helmut Höffken ; Richard C. Dodel ; Karla M. Eggert ; Jens C. MöllerRole of dopamine transporter SPECT for the practitioner and the general neurologist.
003676 (2003) Hani T S. Benamer [Royaume-Uni] ; Wolfgang H. Oertel ; Jim Patterson ; Donald M. Hadley ; Oliver Pogarell ; H. Höffken ; A. Gerstner ; Donald G. GrossetProspective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
003700 (2003) Maria Bozi [Royaume-Uni] ; Kailash P. BhatiaParoxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease.
003733 (2003) Walter Pirker [Autriche] ; Iris Holler ; Willibald Gerschlager ; Susanne Asenbaum ; Georg Zettinig ; Thomas BrückeMeasuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.
003748 (2003) David R. Lynch [États-Unis] ; P David Mozley ; Set Sokol ; Nicole M C. Maas ; Laura J. Balcer ; Andrew D. SiderowfLack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
003804 (2003) George R. Uhl [États-Unis]Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.
003805 (2003) Paola P. Piccini [Royaume-Uni]Dopamine transporter: basic aspects and neuroimaging.
003806 (2003) Andrew J. Lees [Royaume-Uni] ; Donald G. GrossetDopamine transporter imaging.
003807 (2003) Richard C. Dodel [Allemagne] ; Helmut Höffken ; J Carsten Möller ; Bernhard Bornschein ; Thomas Klockgether ; Thomas Behr ; Wolfgang H. Oertel ; Uwe SiebertDopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
003818 (2003) Durval C. Costa [Royaume-Uni] ; Zuzana Walker ; Rodney W H. Walker ; Flávia R G. FontesDementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging.
003824 (2003) Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee ; Si-Ryung Han ; Yong-An ChungDecreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis.
003830 (2003) Walter Pirker [Autriche]Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
003899 (2002) Annie Lannuzel [France] ; Patrick P. Michel ; Dominique Caparros-Lefebvre ; Jacqueline Abaul ; Reynald Hocquemiller ; Merle RubergToxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.
003966 (2002) Walter Pirker [Autriche] ; Schiva Djamshidian ; Susanne Asenbaum ; Willibald Gerschlager ; Gotthard Tribl ; Martha Hoffmann ; Thomas BrückeProgression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
003972 (2002) Joseph H. Friedman [États-Unis]Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3).
003B21 (2002) Y. Kim [Corée du Sud] ; J-M Kim ; J-W Kim ; C-I Yoo ; C R Lee ; J H Lee ; H K Kim ; S O Yang ; H K Chung ; D S Lee ; B. JeonDopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
003B54 (2002) Yun J. Kim [Canada] ; Masanori Ichise ; James R. Ballinger ; Douglas Vines ; Sean S. Erami ; Tatsuro Tatschida ; Anthony E. LangCombination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
003B71 (2002) John L. Goudreau [États-Unis] ; Demetrius M. Maraganore ; Matthew J. Farrer ; Timothy G. Lesnick ; Andrew B. Singleton ; James H. Bower ; John A. Hardy ; Walter A. RoccaCase-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
003B90 (2002) Masataka Nishimura [Japon] ; Ryuji Kaji ; Mitsuhiro Ohta ; Ikuko Mizuta ; Sadako KunoAssociation between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
003C09 (2001) A. Varrone [États-Unis] ; K L Marek ; D. Jennings ; R B Innis ; J P Seibyl[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
004010 (2000) H T Benamer [Royaume-Uni] ; J. Patterson ; D J Wyper ; D M Hadley ; G J Macphee ; D G GrossetCorrelation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Membrane Transport Proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Membrane Transport Proteins
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024